Skip to main content

Table 1 The clinical and surgical features of the patients in this study

From: Usefulness of artificial vascular graft for venous reconstruction in liver surgery

Patient number

Sex/age

Disease

Liver resection (resected segments)

Operation time (min)

Blood loss

(mL)

Vascular resection

Other combined resection

Vascular graft

ICG R15 (%)

Oncological stage

1

F/56

Intrahepatic cholangiocarcinoma

Right trisectionectomy (1, 4 to 8)

548

2285

IVC

Bile duct

20 mm ringed ePTFE tube graft

9.7

3

2

M/67

Intrahepatic cholangiocarcinoma

Left hepatectomy (1 to 4)

503

2230

IVC

None

20 mm ringed ePTFE tube graft

5

4A

3

F/68

Metastatic gastrointestinal stromal tumor

Partial resection (4)

331

820

IVC

None

20 mm ringed ePTFE tube graft

21.2

4

4

M/73

Hepatocellular carcinoma

Right trisectionectomy (1, 4 to 8)

419

3600

LHV

None

10 mm ringed ePTFE tube graft

15.2

2

5

M/50

Sarcomatoid mesothelioma

Right hepatectomy (1,5 to 8)

519

3600

IVC

Diaphragm, lower lobe of right lung

20 mm ringed ePTFE tube graft

3.3

4

6

M/53

Hepatocellular carcinoma

Left hepatectomy (1 to 4)

366

730

MHV

None

10 mm ringed ePTFE tube graft

13.2

3

7

M/84

Metastatic colon cancer

Partial resection (7)

414

1804

IVC

None

ePTFE patch graft

15.2

4

8

M/62

Intrahepatic cholangiocarcinoma

Partial resection (1)

467

1760

IVC

None

20 mm ringed ePTFE tube graft

13.4

3

  1. ePTFE, expanded polytetrafluoroethylene; IVC, inferior vena cava; LHV, left hepatic vein; MHV, middle hepatic vein; ICG R15, indocyanine green retention rate at 15 min.